Evidence map›Paper›PMID 26424611›Full record

ArticleScientific reports2015

Direct chemotherapeutic dual drug delivery through intra-articular injection for synergistic enhancement of rheumatoid arthritis treatment.

A Reum Son, Da Yeon Kim, Seung Hun Park, Ja Yong Jang, Kyungsook Kim, Byoung Ju Kim, Xiang Yun Yin, Jae Ho Kim, Byoung Hyun Min, Dong Keun Han and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

A Reum SonDepartment of Molecular Science and Technology, Ajou University, Suwon 443-759, Korea.
Da Yeon KimDepartment of Molecular Science and Technology, Ajou University, Suwon 443-759, Korea.
Seung Hun ParkDepartment of Molecular Science and Technology, Ajou University, Suwon 443-759, Korea.
Ja Yong JangDepartment of Molecular Science and Technology, Ajou University, Suwon 443-759, Korea.
Kyungsook KimDepartment of Molecular Science and Technology, Ajou University, Suwon 443-759, Korea.
Byoung Ju KimDepartment of Molecular Science and Technology, Ajou University, Suwon 443-759, Korea.
Xiang Yun YinDepartment of Orthopedic Surgery, School of Medicine, Ajou University, Suwon 443-759, Korea.
Jae Ho KimDepartment of Molecular Science and Technology, Ajou University, Suwon 443-759, Korea.
Byoung Hyun MinDepartment of Molecular Science and Technology, Ajou University, Suwon 443-759, Korea.
Dong Keun HanBiomaterials Research Center, Korea Institute of Science and Technology, Seoul 130-650, Korea.
Moon Suk KimDepartment of Molecular Science and Technology, Ajou University, Suwon 443-759, Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The effectiveness of systemic rheumatoid arthritis (RA) treatments is limited by difficulties in achieving therapeutic doses within articular joints. We evaluated the ability of intra-articular administration of injectable formulations to synergistically enhance repair of RA joints. Methotrexate-loaded hyaluronic acid (Met-HA), dexamethasone-loaded microcapsules (Dex-M), and Dex-M dispersed inside Met-HA were prepared as viscous emulsions and injected into articular joints using a needle to form a drug depot. By near-infrared (NIR) fluorescence imaging, we confirmed the local release of NIR from the depot injected into the articular joint over an extended period. In comparison with the subjects treated with Met-HA or Dex-M alone, subjects treated simultaneously with Met-HA and Dex-M exhibited faster and more significant RA repair. Collectively, these results indicated that the drug depot formed after intra-articular injection of Met-HA/Dex-M induced long-lasting drug release and allowed Met and Dex to effectively act in the articular joint, resulting in enhanced RA repair.

Indexed as

AnimalsAnti-Inflammatory AgentsAntirheumatic AgentsArthritis, RheumatoidBiomarkersCell LineChemistry, PharmaceuticalDexamethasoneDisease Models, AnimalDrug SynergismDrug Therapy, CombinationHumansImmunohistochemistryInjections, Intra-ArticularMaleMethotrexateAnti-Inflammatory AgentsAntirheumatic AgentsBiomarkersDexamethasoneMethotrexate

Identifiers

PMID26424611
PMCPMC4589689

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.